Monell Chemical Senses Center

Monell Chemical Senses Center, a Philadelphia-based tax-exempt nonprofit research institute, acts as a federal grant recipient and occasional service-contract performer delivering specialized human and animal chemosensory testing, neuroscience research, and technical consulting to the National Institutes of Health and other HHS agencies as a prime recipient in 83% of its recent awards.

Monell's core capability is basic and translational research on the chemical senses—taste, smell, and related sensory mechanisms—with application to human health conditions including obesity, neurodegeneration, post-viral dysfunction, and aging. The institute operates proprietary sensory testing instruments (including the Monell Flavor Quiz and Scentinel smell test), maintains specialized animal models, and conducts human clinical research on chemosensory perception and its neural correlates. Representative prime grant work includes a $2.654 million National Institute on Deafness and Other Communication Disorders clinical research center (award date March 1, 2026) investigating inflammation-driven taste and smell loss following COVID-19, with three integrated research projects and organoid development; a $770,450 NIH Office of the Director Trans-NIH Research Support grant (award date September 1, 2026) examining arctic ground squirrel hibernation as a model for metabolic resilience and chronic disease therapeutics; and an $828,937 National Institute of Diabetes and Digestive and Kidney Diseases randomized controlled trial (award date August 1, 2026) parsing orosensory sweetness and caloric signaling in beverage brand conditioning using human neuroimaging. On the contract side, Monell delivered $60,000 in data collection and alcohol-chemosensory perception testing services to the National Institute on Alcohol Abuse and Alcoholism at the 2026 Twinsburg Twin Festival (award date March 10, 2026, sole source).

Customer concentration is tightly clustered within NIH. The top five funding agencies account for 75% of recent awards by count, dominated by NIH and subordinate institutes: the National Institute on Deafness and Other Communication Disorders (41 awards), NIH broadly (43 awards), the National Institute of Diabetes and Digestive and Kidney Diseases (16 awards), the Department of Agriculture Animal and Plant Health Inspection Service (26 awards), and the Department of the Army (7 awards). By potential value, 100% of recent awards ($264 thousand total combined potential value) flows through HHS and NIAAA. Monell holds a single named parent vehicle—an Army Indefinite Delivery Contract (DAAG2982K0192) from which it has drawn three task orders.

Activity accelerated in 2024 (16 awards) after two flat years (2022–2023 at 6 awards each), with 2026 returning to 16 awards and 2025 dipping to 9. Six awards carrying a combined potential value of $60 thousand reach ultimate completion within the next twenty-four months, representing recompete exposure. The source documents $156.8 million obligated against $264 thousand combined potential value—a reporting artifact reflecting the gap between contract ceiling values and actual obligation—indicating that Monell's recent grants are predominantly in their initial or early obligation phases.

Monell operates as a sub-recipient on NIH grants anchored at peer research institutions. Named prime grantees include Georgia State University Research Foundation, the University of Pennsylvania, Tulane Educational Fund, Stanford University, Northwestern University, New York University, University of North Carolina at Chapel Hill, Colorado State University, and others. Sub-award work performed by Monell encompasses nodose ganglia neural manipulation for gut-brain signaling studies, single-cell RNA sequencing data processing and analysis (scRNA-seq), organoid development and viral response testing for respiratory tissue, behavioral and psychophysical testing in human sensory studies, headspace volatile analysis of animal samples for infectious disease detection, and electrophysiology support. The institute supplies scientific personnel (often principal or co-investigators) and specialized facilities to multi-institutional consortia, performing bounded technical work such as Aim-specific experimental execution, data processing, and analysis.

SCI-reported service-contract invoicing is minimal: the dataset captures zero prime service contracts above the $150,000 threshold and four sub-records totaling 5.3 FTEs across FY2024–FY2025, indicating that Monell's federal revenue is overwhelmingly grant-driven rather than service-contract-driven. The institute does not pursue or hold government-wide acquisition contracts, blanket purchase agreements, or commercial schedules. Federal work is conducted in Philadelphia, Pennsylvania, with performance periods typically spanning four to five years on NIH project grants.